TSCO
51
-4
KMB
40
-4
KMI
61
-2
KSS
52
-2
V
62
-4
PFE
40
8
PEG
44
-2
GOOG
87
2
CRM
57
2
AAP
24
-3
HCP
72
-2
ABBV
68
-2
FMC
29
-2
NTAP
67
2
A
37
-3
MUR
38
-6
PM
62
2
MHK
43
-5
URI
66
-2
SIG
49
-3
TSCO
51
-4
KMB
40
-4
KMI
61
-2
KSS
52
-2
V
62
-4
PFE
40
8
PEG
44
-2
GOOG
87
2
CRM
57
2
AAP
24
-3
HCP
72
-2
ABBV
68
-2
FMC
29
-2
NTAP
67
2
A
37
-3
MUR
38
-6
PM
62
2
MHK
43
-5
URI
66
-2
SIG
49
-3
Financhill
Back

Cellectis SA Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
29

CLLS
Cellectis SA

Last Price:
1.85
Seasonality Move:
1.81%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
40.35
Seasonality Move:
-0.9%
Sell
29
Cellectis SA (CLLS) is a Sell

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $1.93. The Score for CLLS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • CLLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $1.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 22.19 Sell
Chaikin Money Flow: 44193 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.16 - 2.84) Sell
Bollinger Bands (100): (2.4 - 2.96) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.06 Sell
20-day SMA: 2.4 Sell
50-day SMA: 2.65 Sell
200-day SMA: 2.52 Sell
8-day EMA: 2.06 Sell
20-day EMA: 2.32 Sell
50-day EMA: 2.55 Sell
200-day EMA: 2.59 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.47 per share, and a decrease next year of $0.53 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):